Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Contemp Clin Trials. 2012 Jun 8;33(5):933–941. doi: 10.1016/j.cct.2012.06.001

Table 2. State Fixed Effects Regression Model Results.

β 95% CI
State Coverage Mandate 2.95 −11.48, 17.38
Year (referent 1991)
   1992 −4.35 −10.66, 1.96
   1993 −12.97** −21.98, −3.95
   1994 −14.77** −23.63, −5.91
   1995 −14.33** −23.45, −5.20
   1996 −4.73 −16.98, 7.51
   1997 6.61 −4.32, 17.55
   1998 13.81* 1.48, 26.14
   1999 10.83 −3.03, 24.69
   2000 13.05 −0.25, 26.36
   2001 16.34* 2.94, 29.74
   2002 −4.69 −17.87, 8.50
   2003 −7.41 −20.26, 5.44
   2004 16.10* 1.57, 30.63
   2005 25.04** 8.10, 41.98
   2006 1.55 −10.55, 13.65
   2007 4.31 −9.91, 18.52
Minority-base CCOP −27.06** −43.07, −11.06
Number of MDs Participating 3.11*** 2.00, 4.23
Number of MDs Squared −0.02** −0.04, −0.01
Number of Components:1-25th percentile 2.43 −6.36, 11.22
Number of Components: 26-50th percentile 0.51 −5.86, 6.88
Number of Components: 51-75th percentile 0.78 −8.41, 9.98
Number of Components: 76-100th percentile 4.05*** 1.99, 6.12
Region (referent Midwest)
   Northeast¥ --
   South¥ --
   West¥ --
Constant N 40.85** 15.86, 65.84 883
N 883

95% Confidence Intervals calculated with Huber-White robust standard errors

*

statistically significant at p<0.05

**

statistically significant at p<0.01

***

statistically significant at P<0.001

¥

Time-invariant at the state level, not estimated in state fixed effect model